January 30, 2019
Study Of The Impact Of Inlyta In 2nd Line On The Treatment Outcomes Of mRCC Patients Treated With Sutent In 1st Line In The Real Life Setting
Read More
December 10, 2018
Use of Biosimilar Nivestim® to Prevent Chemo-induced Neutropenia. Real Life Study
Read More
X